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Abstract
Background: Spontaneous bacterial peritonitis (SBP) is common in hospitalized cir-
rhotic patients with ascites and carries high mortality. This study aimed to determine
whether early diagnostic paracentesis (EDP) <12 h of hospitalization conveys an
intermediate-term (6-month) survival benefit in cirrhotic patients diagnosed with SBP.
Methods: Consecutive US veterans with cirrhosis diagnosed with SBP over 13 years
at a single VA medical center were reviewed retrospectively. Kaplan-Meyer analyses
assessed the effects of EDP on survival.
Results: A total of 79 cirrhotic patients were diagnosed with SBP (61.8  8.8 years,
n = 77 male, n = 52 [66.8%] Caucasian, n = 23 [29.1%] African-American). Underly-
ing liver diseases included hepatitis c viral infection (HCV) (17.5%), alcohol (28.6%),
alcohol and HCV (30.1%), and cryptogenic/metabolic (15.9%). Median baseline
model for end-stage liver disease (MELD) was 12 (range 6–34), and median MELD
at presentation was 18. Seven subjects had a history of hepatocellular carcinoma
(11.1%), and 26 (41.3%) presented with sepsis. Thirty-three (52.4%) subjects died
within 6 months after the SBP admission. Of the subjects, 41 (65.1%) underwent
EDP, of which 23 (56.0%) survived at least 6 months, compared to only 7 of the
22 patients (31.8%) undergoing paracentesis >12 h from presentation (P = 0.057).
The maximal benefit of EDP on survival was observed beyond days 14 and 30; at
these time points, no statistical difference in mortality was discernable (P = 0.55 and
0.71). In a multivariate model including age, MELD at admission, hepatocellular can-
cer, and sepsis criteria, EDP (p 0.034) positively impacted patient survival at
6 months.
Conclusions: EDP is associated with improved 6-month mortality in cirrhotic patients
with ascites. In this veteran cohort, EDP was as important as MELD as a predictor of
intermediate-term survival.
Introduction
Spontaneous bacterial peritonitis (SBP) is a significant source of
morbidity and mortality in hospitalized patients with cirrhosis
and ascites.1 While studies have shown a low SBP prevalence
(3.5%) for asymptomatic cirrhotics in the outpatient setting, this
number rises to 11–29% for those admitted to the hospital for
any reason.2 In acknowledgement of the subtle, often-insidious
course that characterizes early stages of SBP, current practice
guidelines recommend diagnostic paracentesis in all patients with
ascites admitted for management of complications of cirrhosis.3–5
Nonetheless, the potential to improve clinical outcomes
through early paracentesis has not been fully explored. A recent
retrospective study of a large national database concluded that
patients with paracentesis performed on the day of admission or
the following day were observed to have a lower mortality rate
(5.5 vs 7.4%, odds ratio [OR] 1.11, 95% confidence interval
[CI] = 0.96–1.28) compared to those who underwent paracentesis
later in the course of their stay.6 Another retrospective study
from two tertiary care centers demonstrated higher rates of in-
house mortality (adjusted OR 2.7, 95% CI = 1.3–4.8) among
patients receiving delayed paracentesis, defined as later than 12 h
from presentation.7 This, along with model for end-stage liver
disease (MELD) scores, has been shown to be a significant pre-
dictor of mortality in hospitalized patients.8,9
Like many medical centers, our facility does not have a
protocol in place to perform paracentesis in patients admitted
with cirrhosis and ascites. This retrospective analysis was thus
performed to determine whether the timing of paracentesis is
doi:10.1002/jgh3.12290
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associated with increased morbidity and mortality in patients
admitted with cirrhosis-related complications.
Methods
Study subjects. A retrospective cohort study of consecutive
US veterans, ages 20–80 years, with cirrhosis and a diagnosis of
SBP during hospitalization over a 13-year period (1 July 2005 to
1 July 2018) was performed at this single VA Medical Center.
Inclusion criteria were: (i) diagnosis of cirrhosis by ICD-9 and
ICD-10 codes or index history and physical exam (H&P) note,
with ascites noted on index H&P exam; (ii) SBP based on perito-
neal fluid analysis (ascitic fluid absolute neutrophil count [ANC]
of ≥250 cells per mm3)3,10; and (iii) admission for cirrhosis-
related complications (bleed, encephalopathy, worsening ascites,
liver mass, or portal vein thrombosis)11 or nonspecific symptoms,
including fever, tachycardia, leukocytosis, and hypotension.
Exclusion criteria included: (i) admission for a noncirrhosis-
related etiology (e.g. scheduled admission for elective surgical
procedures); (ii) documentation of a bedside ultrasound without
appreciable ascites to attempt for drainage; and (iii) emergent
surgery or patient demise precluding attempt at paracentesis
within the first day of presentation.
Medical records were reviewed to determine baseline char-
acteristics, including age, gender, race/ethnicity, body mass index
(BMI), etiology of chronic liver disease (including alcohol, viral
Hepatitis B/C, or other metabolic, genetic, autoimmune causes),
use of SBP prophylaxis before hospitalization, and other compli-
cations of cirrhosis at presentation (hepatocellular carcinoma
[HCC], renal dysfunction, etc.). Clinical diagnosis of “sepsis” as
listed in the medical record or Sequential (Sepsis-related) Organ
Failure Assessment (SOFA) score of ≥2 were documented.12
MELD scores at the time of admission were calculated. Time
from admission to paracentesis was recorded, as was administra-
tion of albumin and antibiotics. Early diagnostic paracentesis
(EDP) was defined as the performance of the paracentesis within
12 h of presentation; those undergoing paracentesis >12 h
postadmission were categorized in the late diagnostic
paracentesis (LDP) group. Data on patient mortality were col-
lected up to 6 months beyond the index hospital admission.
Statistical analysis. Grouped values are reported as
mean  standard deviation unless otherwise indicated. Between-
group comparisons were performed using Student’s t-tests, and
chi-square analyses were performed for binomial data. Nonpara-
metric testing using independent sample median tests were per-
formed to assess between-group differences in central tendency
for variables with non-Gaussian distribution.
Six-month survival following SBP admission was
implemented, and Kaplan-Meyer analyses assessed the effects
of EDP (≤12 h from presentation) on survival, with generation
of survival plots. Logistic regression models were used to con-
trol for potentially relevant clinical and demographic factors.
Patient factors identified as significant in univariate analysis
were implemented in a final multivariate Cox proportional haz-
ards model. In each case, P < 0.05 was required for statistical
significance.
Results
Demographics and baseline clinical characteris-
tics. A total of 79 cirrhotic patients (61.8  8.8 years, n = 77
male, n = 52 [66.8%] Caucasian, n = 23 [29.1%] African-Ameri-
can) had documentation of SBP following admission to the Saint
Louis Veterans Administration Medical Center (STLVAMC)
during the study period. Of these patients, 16 were excluded
from further analysis due to the performance of a diagnostic
paracentesis prior to presentation. Of the remaining 63 cirrhotic
patients, 32 (65.1%) underwent an early diagnostic paracentesis.
The demographic features and baseline clinical characteristics of
these patients are reported in Table 1. Those who underwent
EDP were younger (P = 0.039) and trended toward having lower
rates of chronic kidney disease (P = 0.055). There were no sig-
nificant differences in baseline MELD, the etiology underlying
chronic liver disease, malignancy diagnoses, or medication regi-
mens between the EDP and LDP groups.
Presenting clinical characteristics. The median time to
paracentesis was 5 h in the EDP group, compared to 42 h in the
LDP cohort (Table 2). There were no significant differences in
presenting MELD in the EDP and LDP subgroups (17.2 vs 18.6,
P = 0.47), although a higher percentage of the LDP group (45.5






(n = 22) P value
Age, years (mean  SD) 60.3  7.0 65.9  11.1 0.039
Male, n (%) 39 (95.1) 22 (100) 0.29
Race, n (%)
Caucasian 26 (63.4) 16 (72.7)
African-American 12 (29.3) 6 (27.3) 0.40
Other 3 (7.3) 0 (0)
Body mass index, kg/m2
(mean  SD)
29.6  6.9 28.6  7.7 0.63
Cirrhosis etiology, n (%)
Hepatitis C 8 (19.5) 3 (13.6)
Alcohol 13 (31.7) 5 (22.7)
Hepatitis C and alcohol 13 (31.7) 6 (27.3) 0.34
Cryptogenic 4 (9.8) 6 (27.3)
Non-alcoholic
steatohepatitis
3 (7.3) 1 (4.5)
Hepatitis B 0 (0) 1 (4.5)
Medical comorbidities, n (%)
Any malignancy 8 (19.5) 4 (18.2) 0.89
Hepatocellular carcinoma 4 (9.8) 3 (13.6) 0.69
Chronic kidney disease 3 (7.3) 6 (27.3) 0.055
Baseline serum creatinine,
mg/dL (mean  SD)
0.93  0.43 1.22  0.64 0.07
Baseline MELD score
(mean  SD)
17.2  6.6 18.5  7.0 0.48
Medication regimen, n (%)
Diuretics 30 (73.2) 13 (59.1) 0.25
Prophylactic antibiotics 6 (14.6) 1 (4.5) 0.41
Proton pump inhibitor 18 (43.9) 6 (27.3) 0.20
MELD, model for end-stage liver disease; SD, standard deviation.
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vs 17.1%, P = 0.02) presented with acute kidney injury. Further-
more, there were no significant differences in leukocyte count,
clinical evidence of sepsis, or medication regimens administered
(antibiotics, albumin, and diuretics) between the paracentesis
subgroups.
Outcomes. Overall, 33 (52.4%) of the study patients died
within 6 months of the index SBP admission. Fewer patients
undergoing EDP died during follow up (18/41, 43.9%) com-
pared to the LDP group (15/22, 68.2%; P = 0.057). The
median time to death was also considerably lower in the EDP
group (46 vs 11 days, P = 0.079). The survival plot of the
EDP and LDP groups is displayed in Figure 1. The survival
benefit of EDP was discernible shortly after admission, with
14-day mortality rates in patients who underwent LDP, more
than twice as high as the EDP group (6/22, 27.3% vs 5/41,
12.2%, P = 0.13).
Predictors of patient survival. A multivariate Cox Pro-
portional Hazard model examining 6-month mortality by timing
of paracentesis was generated (Table 3). Controlling for age,
race, and significant medical comorbidities (malignancy, sepsis
evidence, and acute kidney injury) and use of prophylactic antibi-
otics, patients who underwent EDP had a nearly 60% reduction
in 6-month mortality compared to their LDP counterparts (Exp
(B) 0.42, 95% CI 0.188–0.938, P = 0.034).
Discussion
In this study of a single Veterans Affairs Hospital experience of
consecutive cirrhotic patients hospitalized with an eventual diag-
nosis of SBP, we found a statistically significant survival benefit
in those patients who underwent early diagnostic paracentesis.
This improvement in mortality rate was borne out as far as
6 months beyond the time of presentation, and it held true after
controlling for multiple clinical and demographic factors.
This study is consistent with previously performed stud-
ies showing the importance of the diagnostic paracentesis in
any patient who is hospitalized with decompensated cirrhosis
and a tangible amount of ascites. Our findings also are consis-
tent with prior studies showing that earlier paracentesis trends
toward a benefit in mortality. Orman and colleagues noted, in
a large 2016 study of 17 500 cirrhotic patients, that delays in
the performance of paracentesis (>1 day or 24 h) after admis-
sion resulted in a higher in-hospital mortality, although this
observation did not remain significant in a multivariate analy-
sis.13 Similarly, in a 2016 study by Gaetano et al., there was a
trend toward reduction in inpatient mortality among cirrhotic
patients undergoing earlier paracentesis.6 Another study of
nosocomial SBP observed that mortality impact was sustained
through 90 days, even after the initial SBP episode had
resolved.14 Our study additionally suggests that the mortality
benefit of EDP may extend up to 6 months beyond the index
SBP diagnosis.
Our study is bolstered by the robust nature of the VA Cor-
porate Data Warehouse database, allowing for thorough and stan-
dardized collection of clinical and demographic data, as well as a
full, time-sensitive account of diagnostic testing, administered
therapies, and outcomes.15 From a demographic perspective, the
racially diverse makeup of the examined VA center resulted in a
strong African American representation in this study. Limitations
of the study include its selection bias toward males, alcoholics,
and those with hepatitis C—a quality inherent to all VA-based
population studies on cirrhosis.16 Furthermore, this study was






(n = 22) P value
Time to paracentesis, hours,
median (range)
5 (0–12) 42 (13–192) <0.001
Admission laboratories
Serum creatinine (Scr),
mg/dL (mean  SD)
1.37  1.15 1.84  1.27 0.15
Acute kidney injury,† n (%) 7 (17.1) 10 (45.5) 0.02
MELD score (mean  SD) 17.2  6.6 18.6  7.0 0.47
Leukocyte count, cells/mL
(mean  SD)
11.0  7.9 10.4  5.6 0.75
Serum sodium, mEq/L
(mean  SD)
132.0  6.1 133.8  4,9 0.23
Sepsis,‡ n (%) 18 (43.9) 8 (36.4) 0.69
Medications provided at
admission, n (%)
Albumin 32 (78.0) 14 (63.6) 0.22
Diuretics 30 (69.8) 13 (30.2) 0.25
Death, 6 months, n (%) 18 (43.9) 15 (68.2) 0.057
Median time to death,
days (range)
46 (3–175) 11 (1–131) 0.079
†Acute kidney injury defined as an increase in serum creatinine of ≥0.5
over baseline.
‡Sepsis defined as a documented clinical diagnosis of “sepsis” or a
Sequential (Sepsis-related) Organ Failure Assessment score of ≥2.
MELD, model for end-stage liver disease; SD, standard deviation.
Figure 1 Survival plot of the early diagnostic paracentesis (EDP) and late
diagnostic paracentesis (LDP) groups. SBP, spontaneous bacterial peritonitis.
( ) LDP, ( ) EDP, ( ) LDP-censored, ( ) EDP-censored.
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retrospective, allowing for potential confounding factors in the
care of patients with SBP.
The decision to implement 12 h as the cutoff time to
define early versus late paracentesis reflects the standard set by
previous studies on this topic. At the same time, this time win-
dow highlights the challenges inherent to the current rubric of
decompensated cirrhosis management in the inpatient setting.
First, it necessitates a high index of suspicion in order for an
early diagnosis of SBP may be made, particularly in patients
who do not exhibit obvious vital sign instability to alert providers
to the onset of sepsis. The timely diagnosis and management of
SBP requires the recognition that a history of advanced liver dis-
ease with ascites alone is sufficient to mandate paracentesis. It is
clear that clinical impression alone is inadequate to rule out a
diagnosis of SBP.17 Secondly, as many of these patients are
admitted through the emergency department and indeed may
spend the majority of their initial 12 h following hospital presen-
tation receiving triage care in this setting, the effectiveness of this
EDP approach will require awareness and engagement of emer-
gency department physicians. We believe this study provides a
strong basis for prospective evaluation of protocolized early
paracentesis strategies that could further establish the value of
early (or immediate) paracentesis as a standard of care for the
hospitalized cirrhotic patient with ascites.
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